Shift Bioscience Company
Shift Bioscience is using simulation guided cell rejuvenation to defeat the diseases of aging. Cellular reprogramming with Yamanaka factors can reverse aging in the dish but is not yet safe for clinical use. Shift has pioneered the first high-throughput, high-accuracy aging biomarker, which has been leveraged inside AI-based cell simulations to identify safer rejuvenation gene-factors. Shift envisions the development of a single drug-family that can treat multiple diseases of aging, after which full and continued health into old age becomes accessible by simple prescription.
Founded Date:
2017-07-01
Last Funding Date:
2024-10-15
Industry:
Quantum Biology
Total Funding:
16331095
Headquarters:
Cambridge,Cambridgeshire,United Kingdom,Europe
Employee Number:
11-50
Funding Status:
private
Super Industry:
Quantum Science Applications
Funding Stage:
Seed
Funding Total Value:
12500000
Last Funding Total Usd:
16331095
Last Funding Total Currency:
GBP
Last Funding Total Value:
12500000
Founders:
Brendan Swain,Daniel Ives